After Halting Emergency Use, Brazil Shelves Import Permit Of Covaxin.

After Halting Emergency Use, Brazil Shelves Import Permit Of Covaxin

Bharat Biotech will continue to work with Anvisa, to complete regulatory approval process for Covaxin.

Hyderabad:

After suspending the proposed clinical trials of Bharat Biotech's COVID-19 vaccine Covaxin and a request for Emergency Use Authorisation, Brazil now has suspended its decision to import four million doses of the jab into that country.

According to a statement issued by the National Health Surveillance Agency of Brazil, Anvisa its Collegiate Board on Tuesday took a decision to suspend the exceptional and temporary authorisation for import and distribution of Covaxin after Bharat Biotech informed the South America government about the termination of its pact with its Brazilian partners.

"The Collegiate Board of Anvisaunanimously decided, on Tuesday (27/7), to provisionally suspend the exceptional and temporary authorisation for import and distribution of the vaccine against Covid-19-Covaxin, requested by the Ministry of Health," Anvisa said in a statement posted on its website.

Bharat Biotech on July 23 said it terminated the MoU it entered with Precisa Medicamentos and Envixia Pharmaceuticals LLC for its COVID-19 vaccine Covaxin for the Brazilian market.

The termination of the MoU came after the deal with the Brazilian government for the supply of 20 million doses of Covaxin landed in controversy and attracted investigation by authorities in that country.

"The measure prevails until there is new information that allows us to conclude that the legal and technical security of maintaining the decision that authorised the importation is maintained," Anvisa further said in a roughly translated version of Portuguese of the statement.

Though the exceptional and temporary importation of the vaccine had been authorized on June 4, at the ninth Extraordinary Meeting of the Collegiate Board of Anvisa, Brazil never imported the jab.

Bharat Biotech will continue to work diligently with Anvisa, to complete the regulatory approval process for Covaxin, Bharat Biotech had said while announcing the termination of its pact with its Brazilian partners.

NDTV News

NDTV.com provides latest news from India and the world. Get today’s news headlines from Business, Technology, Bollywood, Cricket, videos, photos, live news coverage and exclusive breaking news from India.

https://www.ndtv.com/

Related news
CNN's Don Lemon blasted for calling to 'shame' unvaccinated people.

CNN's Don Lemon blasted for calling to 'shame' unvaccinated people.

The ‘Outnumbered’ panel reacts to Don Lemon’s comments on CNN where he called on people to start ‘shaming’ unvaccinated Americans. Subscribe to Fox News! Watch more Fox News Video: Watch Fox News Channel Live: FOX News Channel (FNC) is a 24-hour a...

FDA panel expected to vote on a third Pfizer COVID-19 shot ahead of White House deadline.

FDA panel expected to vote on a third Pfizer COVID-19 shot ahead of White House deadline.

A Food and Drug Administration advisory committee is expected to vote on the safety and efficacy of a third dose of the Pfizer-BioNTech vaccine. CBS News' Natalie Brand reports on the debate over whether vaccinated Americans need booster shots, an...

Biden Heads to Delaware for the Weekend

Biden Heads to Delaware for the Weekend

President Joe Biden is heading to Delaware for the weekend. He took off from Joint Base Andrews on Friday after trying hammer out the world's next steps against rapidly worsening climate change in a private, virtual session with a small group of o...

'A mistake': US admits it killed 10 civilians in Kabul airstrike.

'A mistake': US admits it killed 10 civilians in Kabul airstrike.

A United States military investigation into a deadly Kabul drone strike on a vehicle in August has found it killed 10 civilians and the driver and that the vehicle targeted was likely not a threat associated with ISIS-K, announced Gen. Frank McKen...

FDA panel votes against Pfizer's COVID booster shots for ages 16 and up.

FDA panel votes against Pfizer's COVID booster shots for ages 16 and up.

Dr. Marty Makary of Johns Hopkins offers analysis on 'The Story' Subscribe to Fox News! Watch more Fox News Video: Watch Fox News Channel Live: FOX News Channel (FNC) is a 24-hour all-encompassing news service delivering breaking news as well as p...

FDA Panel Votes Against Recommending Covid Booster Shots To Most Americans.

FDA Panel Votes Against Recommending Covid Booster Shots To Most Americans.

An independent review panel of the Food and Drug Administration has voted against recommending a third booster shot for Pfizer's Covid-19 vaccine to Americans over the age of 16. NBC's Mike Memoli has details on the decision.» Subscribe to NBC New...